Related Experiment Video
Updated: Aug 9, 2026
12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Grade II astrocytoma visualized by technetium-99m-ECD SPECT
Summary
This study shows technetium Tc 99m ethyl cysteinate dimer (99mTc-ECD) brain SPECT can detect increased cerebral blood perfusion in a Grade II astrocytoma. This highlights 99mTc-ECD
Area of Science:
- Neurology
- Nuclear Medicine
- Oncology
Background:
- Primary brain tumors require accurate diagnostic imaging.
- Cerebral blood flow imaging agents are used to assess brain tumor characteristics.
- Technetium Tc 99m ethyl cysteinate dimer (99mTc-ECD) is a radiotracer used in brain SPECT imaging.
Observation:
- A case of primary brain tumor (Grade II astrocytoma) was evaluated.
- The tumor demonstrated increased uptake of 99mTc-ECD on brain SPECT scans.
- Dynamic imaging revealed significantly increased cerebral blood perfusion.
- Static imaging showed homogeneously increased uptake.
Findings:
- 99mTc-ECD brain SPECT effectively visualized increased cerebral blood perfusion in a Grade II astrocytoma.
- The uptake was homogeneous on static imaging, indicating significant perfusion.
- Potential differences in perfusion and uptake mechanisms exist compared to other agents like 99mTc-HMPAO, [123I]-IMP, and 201TI-chloride.
Implications:
- 99mTc-ECD SPECT may serve as a valuable tool for assessing primary brain tumors.
- Understanding agent-specific characteristics can aid in selecting the optimal imaging modality.
- Further research is warranted to elucidate the differences in perfusion and uptake mechanisms among various cerebral blood flow agents.
